- Home
- RVMD
as 12-20-2024 4:00pm EST
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 8.7B | IPO Year: | 2020 |
| Target Price: | $64.67 | AVG Volume (30 days): | 2.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.56 | EPS Growth: | N/A |
| 52 Week Low/High: | $25.93 - $62.40 | Next Earning Date: | 11-06-2024 |
| Revenue: | $742,000 | Revenue Growth: | -97.16% |
| Revenue Growth (this year): | -97.17% | Revenue Growth (next year): | 1855.42% |
Latest Revolution Medicines Inc. News
RVMD Breaking Stock News: Dive into RVMD Ticker-Specific Updates for Smart Investing
Simply Wall St.
10 days ago
One Revolution Medicines Insider Raised Their Stake In The Previous Year
MT Newswires
16 days ago
Wedbush Cuts Price Target on Revolution Medicines to $67 From $70, Keeps Outperform Rating
MT Newswires
16 days ago
Revolution Medicines Closes Offering of 16.6 Million Shares
GlobeNewswire
16 days ago
Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares
TipRanks
18 days ago
Revolution Medicines price target raised to $87 from $82 at Guggenheim
MT Newswires
18 days ago
Revolution Medicines Prices $45 Million Stock, Warrant Offering
GlobeNewswire
18 days ago
Revolution Medicines Announces Pricing of Upsized $750.0 Million Public Offering of Common Stock and Pre-Funded Warrants
MT Newswires
19 days ago
Revolution Medicines Launches $600 Million Offering of Common Shares
Compare RVMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RVMD Revolution Medicines Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.